CHICAGO / Dec 12, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) will announce its fourth quarter and full year 2024 financial results before the market opens on Thursday, February 13, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at... Read More

More than 80 percent of all health system visits include an imaging exam, i making radiology an essential part of diagnostics and healthcare and image quality a cornerstone of medicine. GE HealthCare is at the forefront of leveraging deep learning, a subset of artificial intelligence (AI), to benefit clinicians and patients with the latest technologies and solutions. CHICAGO / Dec 05, 2024 / Business Wire / GE HealthCare... Read More

Determined to reach net zero emissions by 2050, GE HealthCare’s portfolio features environmentally conscious product design, energy efficiency, and technology circularity while continuing to drive advancements in patient care CHICAGO / Dec 04, 2024 / Business Wire / As part of a companywide commitment to advance innovation that improves the health of patients and the planet, GE HealthCare (Nasdaq: GEHC) is highlighting... Read More

CleaRecon DL* is designed to improve cone-beam computed tomography (CBCT) image quality by removing streaks and help clinicians improve their confidence in image interpretation when analyzing CBCT data CHICAGO / Dec 03, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve the quality... Read More

GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP, subject to regulatory approvals As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, will enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease... Read More

New 3D imaging capabilities of Sonic DL are designed to enable up to 86% i faster scans and enhanced resolution for brain, spine, orthopedic and body imaging. Combination of Sonic DL and AIR Recon DL accelerates workflow while improving diagnostic confidence and patient comfort. CHICAGO / Dec 01, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today unveiled Sonic DL for 3D ii , the newest addition to its effortless... Read More

Booth (#7330) will showcase new innovations that address the most pressing challenges in healthcare, spanning the care journey across devices, disease states and digital tools New product introductions reflect GE HealthCare’s increased R&D investment since 2022 CHICAGO / Dec 01, 2024 / Business Wire / At the Radiological Society of North America’s (RSNA) 2024 Annual Meeting taking place from Dec. 1-4 in Chicago, GE... Read More

Amid technologist shortage, new mammography innovation was designed through intensive collaboration with technologists will help to streamline workflow and humanize care CHICAGO / Nov 26, 2024 / Business Wire / Today GE HealthCare announced the new Pristina Via™* mammography system designed to enhance the screening experience for both technologists and patients. Debuting at the Radiological Society of North America’s 2024... Read More

CHICAGO / Nov 25, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. Nasdaq Investor Conference in London, England - December 10, 2024 at 11:00 am GMT / 5:00 am CT / 6:00 am ET 43 rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA - January 14, 2025 at 4:15 pm CT / 5:15 pm ET Webcasts of these events... Read More

To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added Lung Suite to their OEC 3D m-CBCT offering. OEC Open interface expanded with additional third-party option to streamline data interface during bronchoscopy procedures. CHICAGO / Nov 22, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announces additional clinical applications now available as part of the... Read More

Company updates medium-term framework with progress toward financial goals; increases quarterly cash dividend by approximately 17% CHICAGO / Nov 21, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) will host its Investor Day today at Nasdaq MarketSite in New York, NY. The event begins at 8:00 am ET / 7:00 am CT and can be viewed virtually here . Registration is required for in-person attendance. The event will feature... Read More

Published in the Journal of Clinical Anesthesia , results from the two-phase, 250 patient pilot study show clinicians found a majority (82%) of the alarms from the wireless and wearable Portrait Mobile monitoring solution to be informative or useful to optimize patient care in medical-surgical units. 1 Study findings suggest that continuous monitoring helps provide critical information to clinicians, enabling them to... Read More

New MRI technology aims to advance neuroimaging and biomarker research CHICAGO / Nov 13, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS, i a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner. This system offers new capabilities for both clinical imaging and neuroscience with the potential to aid in the detection of neurological,... Read More

Factors impacting today’s critical shortage of radiologic technologists include clinician burnout, the impact of COVID and COVID-related policies, and demand for radiologic technologists outpacing today’s number of trained clinicians. GE HealthCare and AMN Healthcare are working together to enable training and development of the next generation of radiologic technologists to help address this critical clinician shortage and... Read More

CHICAGO / Nov 07, 2024 / Business Wire / GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 13,281,302 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the... Read More

CHICAGO / Nov 07, 2024 / Business Wire / GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 13,281,302 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the... Read More

CHICAGO / Nov 07, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) will host its Investor Day on Thursday, November 21, 2024, at Nasdaq MarketSite in New York, NY, where its management team will present its growth strategies, technology portfolio, and vision for its businesses. A technology showcase will follow the presentations for in-person attendees. Registration is required. The live webcast will be available at... Read More

Revenue growth was 1% year-over-year; Organic revenue growth* was 1% Net income margin was 9.7% versus 7.8% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 16.3% versus 15.4% Diluted earnings per share (EPS) were $1.02 versus $0.83 for the prior year; Adjusted EPS* was $1.14 versus $0.99 Cash flow from operating activities was $742 million versus $650 million for the prior year; Free cash... Read More

Application goes beyond data aggregation to help clinicians quickly see a longitudinal view of their patient’s history, spotlighting disease progression and helping to inform proactive interventions Tampa General Hospital and UT Southwestern Medical Center to be early evaluators of CareIntellect for Oncology Application is the first within GE HealthCare’s new CareIntellect offering of clinical and operational applications,... Read More

Innovations include Health Companion research project powered by agentic AI Additional early innovations explore pressing care needs, including identifying new ways to detect breast cancer and improving quality of care for moms and babies CHICAGO / Oct 21, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a new AI Innovation Lab, an initiative designed to accelerate early-concept AI innovations within the... Read More

The “Powering Milwaukee Forward” initiative will fund 10 Milwaukee organizations to increase access to basic needs and maternal healthcare in vulnerable communities. MILWAUKEE / Oct 18, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation (CAFF), teamed up to launch a new philanthropic endeavor, Powering Milwaukee Forward, aimed at improving access... Read More

GE HealthCare announces Hospital Pulse, the newest tile for its Command Center Software Platform CHICAGO / Oct 17, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a new tile for its Command Center Software: Hospital Pulse. Hospital Pulse Tile pulls in real-time information from across departments to quickly surface the most vital information about a healthcare system’s operations in a customizable... Read More

Bringing together leading global healthcare innovator and European healthcare institutions, this relationship aims to advance Theranostics in clinical practice and the development of new tracers and technologies for more personalized medicine Theranostics is a transformative approach to cancer treatment, giving hope to patients and their loved ones and the potential for an improved quality of life The practice of... Read More

Versana Premier is designed to feel familiar from day one, simplifying workflow and making it easier for clinicians in multiple-purpose practices to deliver high-quality care to a wide range of patient populations and care scenarios Powered by VisionBoost Architecture, Versana Premier offers an advanced imaging platform designed to deliver exceptional image quality with its next generation image engine, first-class display... Read More

Integrated feature from Blackford offers AI-enabled decision support to help radiologists adapt to higher workloads and increased exam complexity CHICAGO / Oct 09, 2024 / Business Wire / GE HealthCare integrates third party artificial intelligence (AI)-enabled application orchestration feature into True PACS and Centricity PACS. 1 In collaboration with Blackford, the new AI-enabled offerings help radiologists with their... Read More

CHICAGO / Oct 08, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2024 financial results before the market opens on Wednesday, October 30, 2024. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events... Read More

CHICAGO / Oct 07, 2024 / Business Wire / GE HealthCare announces the commencement, and its leading industrial role, in Thera4Care, an initiative aimed at revolutionizing the use of theranostics to broaden patient access in Europe. The €25.3 million project gathers 29 partners from top European academic and clinical sites, small and medium-sized enterprises, and patient advocacy groups. Cancer is the leading cause of death... Read More

Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well tolerated with no serious adverse events, dose-limiting toxicities or clinically relevant findings reported. If approved, this agent... Read More

GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, the predominant procedure used in nuclear cardiology today With a half-life over ten times longer than currently approved cardiac... Read More

CHICAGO / Sep 26, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced its latest innovations in radiation oncology that will be showcased at the American Society for Radiation Oncology (ASTRO) 2024 conference in Washington, DC. These novel solutions aim to improve the entirety of the radiation therapy workflow for clinicians and cancer patients. It is estimated that 470,000 patients receive radiotherapy each... Read More

Unveiling Venue Sprint™, the latest Venue family solution offering maximum portability and advanced capabilities for high-quality scanning and support at the point of care Venue family enhancements include advanced software and wireless flexibility with the integration of Vscan Air™ probes CHICAGO / Sep 19, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of enhanced Venue ultrasound systems and... Read More

CHICAGO / Sep 18, 2024 / Business Wire / The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per share of Common Stock for the third quarter of 2024 payable on November 15, 2024 to all shareholders of record as of October 18, 2024. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital... Read More

CHICAGO / Sep 12, 2024 / Business Wire / GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 15,000,000 shares of its common stock (the “GEHC Shares”) at a public offering price of $86.00 per share. The Offering was upsized from the previously announced offering size of 10,000,000... Read More

CHICAGO / Sep 12, 2024 / Business Wire / GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 10,000,000 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the... Read More

CE mark of these next-generation cardiac imaging systems will further enable connected care along the cardiology patient journey and provide clinicians with the tools to deliver more efficient and timely care CHICAGO / Aug 26, 2024 / Business Wire / Today, GE HealthCare (Nasdaq: GEHC) announced the CE marks of its Vscan Air™ SL wireless handheld ultrasound system with Caption AI™ (Vscan Air SL with Caption AI), an artificial... Read More

CHICAGO / Aug 21, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announced today that management will present at the following September investor conferences. 2024 Wells Fargo Healthcare Conference in Boston on September 4, 2024 at 10:15 am ET/9:15 am CT Morgan Stanley 22 nd Annual Global Healthcare Conference in New York on September 5, 2024 at 1:05 pm ET/12:05 pm CT These events can be accessed at the GE HealthCare... Read More

Published in Anesthesia and Analgesia , results from the multi-site trial evaluating End-tidal Control software provide compelling evidence for enhanced accuracy and efficiency of anesthesia delivery compared to conventional anesthetic gas delivery methods. 1 End-tidal Control is the first FDA-approved software that automatically adjusts and maintains exhaled oxygen and exhaled anesthetic concentrations, with more accuracy... Read More

Project aims to increase access of advanced imaging techniques for clinicians to help drive improved diagnosis and management of female pelvic diseases and conditions, such as endometriosis and ovarian cancer. The Center for Translational Imaging and Precision Medicine (CTIPM) at the University of California San Diego School of Medicine will develop new magnetic resonance imaging (MRI) protocols and educational materials for... Read More

Revenues were flat year-over-year; Organic revenue growth* was 1% Net income margin was 8.9% versus 8.7% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 15.3% versus 14.8% Diluted earnings per share (EPS) were $0.93 versus $0.91 for the prior year; Adjusted EPS* was $1.00 versus $0.92 Cash flow from operating activities was $(119) million versus $(67) million for the prior year; Free cash... Read More

GE HealthCare selects AWS as its strategic cloud provider to deliver entirely new, purpose-built foundation models designed to fast-track the development of innovative healthcare applications GE HealthCare plans to train and deploy clinical foundation models on AWS’s machine learning and generative AI technologies to help healthcare providers expedite clinical and operational workflows to improve delivery of care CHICAGO /... Read More

Agreement to acquire business adds innovative, real-time image recognition technology and expertise to GE HealthCare’s portfolio of AI-enabled devices AI-based technology from Intelligent Ultrasound aims to provide real-time support for OBGYN scans and improve exam accuracy and efficiency Planned acquisition supports GE HealthCare’s precision care strategy to address inefficiencies and improve patient care quality CHICAGO /... Read More

CHICAGO / Jul 08, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, will announce its second quarter 2024 financial results before the market opens on Wednesday, July 31, 2024. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time on that same day, which will be a live... Read More

CHICAGO / Jun 26, 2024 / Business Wire / The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per share of Common Stock for the second quarter of 2024 payable on August 15, 2024 to all shareholders of record as of July 19, 2024. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital... Read More

ALBUQUERQUE, N.M. / Jun 24, 2024 / Business Wire / Today Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare (Nasdaq: GEHC) announced HHNM as the first location in the United States to install GE HealthCare’s latest Allia Image Guided System (IGS) Pulse, which was designed to provide exceptional image quality and improve workflow for the diagnosis and treatment of cardiovascular diseases (CVD).... Read More

GE HealthCare and MediView XR, Inc. announce the first installation and clinical use of augmented reality solution OmnifyXR Interventional Suite at North Star Vascular and Interventional in Minnesota. Heads-up holographic display aims to transform the interventional room and help advance the delivery of precision care across a... Read More

Roland Rott, the current president and CEO of Ultrasound, will lead Imaging, replacing Jan Makela Philip Rackliffe, the current president and CEO of Image Guided Therapies (IGT), will lead Ultrasound and IGT CHICAGO / Jun 10, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announced today that it has named Roland Rott president and CEO of Imaging and Phil Rackliffe president and CEO of Ultrasound and IGT. Both leaders... Read More

At #SNMMI24, GE HealthCare expands its technology with the addition of a MINItrace Magni, i designed to be a small footprint cyclotron for reliable, in-house production of commercial PET tracers and radiometals; Omni Legend 21 cm, ii a performance-focused PET/CT designed to evolve and help meet growing healthcare system demands across care areas; and Clarify DL, iii a new deep learning reconstruction technology designed to... Read More

Adding a PET/CT scan with [ 18 F]FES, a breast oncology PET tracer, may increase the accuracy of knowing the estrogen receptor (ER) status. This is notable when a tumor sample cannot be obtained, or the risk of a biopsy-related complication is high. Increased diagnostic accuracy may help clinicians select more effective treatments and decrease the rate of re-biopsies, resulting in the potential cost savings of $142M to the... Read More

CHICAGO / May 30, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leading medical technology innovator, and Tampa General Hospital (TGH), one of the nation’s leading academic health systems, continue to strengthen their long-term partnership by announcing an agreement to deploy GE HealthCare’s Imaging and Ultrasound technology solutions to benefit clinicians and patients in TGH Imaging’s outpatient facilities across... Read More

FDA’s list of AI-enabled device authorizations includes more than 850 devices; 72 are from GE HealthCare – more than any other medical technology company CHICAGO / May 22, 2024 / Business Wire / GE HealthCare has topped a U.S. Food and Drug Administration (FDA) list of artificial intelligence (AI) enabled medical devices for the third year in a row with 72 listed 510(k) clearances or authorizations to date in the United... Read More

Collaboration seeks to advance precision care by providing an alternative, non-invasive approach to the assessment of coronary physiology. Both companies will focus on the integration of Medis QFR into GE HealthCare’s cath lab environment built around the Allia Platform to enable a seamless user experience. CHICAGO / May 14, 2024 / Business Wire / Today, GE HealthCare (Nasdaq: GEHC), a leading global medical technology,... Read More

CHICAGO / May 06, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will host an investor day on Thursday, November 21, 2024, in New York, NY. GE HealthCare’s management team will present its growth strategies, technology portfolio, and vision for its businesses via a live webcast and will be accessible at https://investor.gehealthcare.com/news-events/events . More information,... Read More

SIGNA MAGNUS i is a high-performance head-only MR scanner from GE HealthCare that could expand the field of neuroscience, which has been limited by the performance of conventional whole-body MR systems thus far. This system is designed to advance MR research in complex imaging procedures in neurology, oncology & psychiatry. CHICAGO / May 05, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA MAGNUS, an... Read More

CHICAGO / May 02, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), is announcing that its Vice President and Chief Financial Officer, Jay Saccaro will be presenting at the following upcoming investor conferences. Bank of America Securities 2024 Healthcare Conference in Las Vegas – May 14, 2024 at 1:00 pm ET/10:00 am PT Jefferies Global Healthcare Conference in New York – June 5, 2024 at 10:00 am ET These events can be... Read More

Company unveiling innovations which harness the power of AI to optimize the complex radiation therapy workflow and enable personalized, more timely care for patients across the cancer care continuum CHICAGO / May 01, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced Revolution RT, i a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase... Read More

Revenues declined 1% year-over-year; Organic revenue growth* was approximately flat Net income margin was 8.0% versus 7.9% for the prior year; Adjusted Earnings Before Interest and Taxes (EBIT) margin* was 14.7% versus 14.1% Diluted earnings per share (EPS) were $0.81 versus $0.41 for the prior year; Adjusted EPS* was $0.90 versus $0.85 Cash flow from operating activities was $419 million versus $468 million for the prior... Read More

The portable vital signs monitor (VSM) adds to GE HealthCare’s growing Portrait Ecosystem to help clinicians make timely treatment decisions and detect patient deterioration earlier with a streamlined spot check workflow, while ensuring patient mobility. Portrait VSM uses proven and innovative capabilities to provide precise... Read More

Collaboration has always been important in the healthcare industry, but in this era of digital health, teamwork across institutions has become essential Enhancing Elekta’s radiation therapy offerings with GE HealthCare’s MIM Software medical imaging management solutions will help drive greater benefits for global healthcare systems This new collaboration complements GE HealthCare and Elekta’s existing global commercial... Read More

Integrated artificial intelligence (AI) and advanced tools improve image quality and exam speed to help providers make accurate diagnoses and tailor precision care for women Latest Voluson Signature ultrasound technology offers an intuitive and ergonomic design allowing clinicians to focus on patient care CHICAGO / Apr 18, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of the Voluson Signature... Read More

Radiologists at Muhimbili National Hospital, part of the Muhimbili University of Health and Sciences and the largest public hospital in Tanzania, will receive the latest mammography technology and advanced imaging training to help clinicians improve detection, diagnosis and treatment of breast cancer in the country. The project aims to help lower Tanzania’s 50% breast cancer mortality rate through early detection and efforts... Read More

The latest MyBreastAI Suite* supports clinicians in accelerating breast cancer detection, while the company’s Pristina Bright** solution helps healthcare providers start a new contrast program. MONTREAL / Apr 12, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leader in breast health technology and diagnostics, will feature its latest breast cancer detection technology during the 2024 Society of Breast Imaging... Read More

CHICAGO / Apr 09, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its first quarter 2024 financial results before the market opens on Tuesday, April 30, 2024. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time on that same day, which will be a live webcast and accessible at... Read More

Caption AI on Vscan Air SL expands access to cardiac care by enabling more medical professionals to feel confident acquiring images for rapid assessments AutoEF feature automatically calculates ejection fraction, saving time for clinicians while delivering key information for making their diagnoses GE HealthCare to debut new technology at 2024 American College of Cardiology Annual Scientific Session & Expo, April 6 – 8, 2024... Read More

With the addition of MIM Software, GE HealthCare aims to provide clinicians and healthcare systems with increasingly integrated and automated solutions, meeting the evolving needs of providers, and reinforcing a shared legacy of advanced patient care solutions Portfolio additions include AI-enabled image analysis and workflow tools spanning multiple care areas, including oncology, urology, neurology, and cardiology CHICAGO /... Read More

Prostate Volume Assist (PVA) is the company’s proprietary urology-based artificial intelligence (AI) software feature designed to automate the manual process for generating prostate volume measurements New AI software feature will be available for use on the bkActiv, bk3000/5000 and bkSpecto active imaging systems Addition of AI solution advances leadership in urological active imaging CHICAGO / Mar 27, 2024 / Business Wire... Read More

GE HealthCare to exclusively distribute nCommand Lite by IONIC Health for multi-vendor, multi-modality remote operations capabilities CHICAGO / Mar 25, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announces the U.S. FDA 510(k) Clearance of IONIC Health’s nCommand Lite technology. The vendor-agnostic, multi-modality nCommand Lite system will be distributed exclusively by GE HealthCare and will provide remote patient... Read More

CHICAGO / Mar 22, 2024 / Business Wire / The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per share of Common Stock for the first quarter of 2024 payable on May 15, 2024 to all shareholders of record as of April 19, 2024. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions... Read More

Multi-modality showcase brings hands-on experience to care delivery for a wide range of vascular diseases and health conditions Scientific studies provide evidence that Embo ASSIST solution can help clinicians reduce patient dose, fluoroscopy time and overall procedure time while performing prostate artery embolization (PAE) CHICAGO / Mar 22, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) will showcase its latest... Read More

Using NVIDIA Technology, SonoSAMTrack¹ demonstrates its pliability and applicability in ultrasound image segmentation, consistently delivering high-quality results over a wide range of demanding datasets and conditions SAN JOSE, Calif. / Mar 18, 2024 / Business Wire / Building on a long-term artificial intelligence (AI) collaboration, GE HealthCare used NVIDIA technology to develop its recent research model SonoSAMTrack 1 ,... Read More

The Care Alliance agreement features a systematic approach focused on innovation, patient and staff experience, and imaging advancements through 2030 HARTFORD, Conn. / Mar 14, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and Connecticut-based Hartford HealthCare today announced that they have renewed a seven-year... Read More

Building on GE HealthCare’s legacy in medical technology, the GE HealthCare Foundation will advance equitable access to precision healthcare with an initial focus on improving maternal health outcomes globally CHICAGO / Mar 13, 2024 / Business Wire / Today, GE HealthCare (Nasdaq: GEHC) a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, announced the establishment of its... Read More

CHICAGO / Mar 12, 2024 / Business Wire / GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 14,000,000 shares of its common stock (the “GEHC Shares”). The Offering was upsized from the previously announced offering size of 13,000,000 GEHC Shares. GE HealthCare is not selling any... Read More

CHICAGO / Mar 12, 2024 / Business Wire / GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 13,000,000 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the... Read More

ORLANDO, Fla. / Mar 12, 2024 / Business Wire / Based on its long-term artificial intelligence (AI) partnership, GE HealthCare and Mass General Brigham plan to integrate medical imaging foundation models into their AI research work, with a strong focus on responsible AI practices. Both organizations have been working closely on AI solutions since announcing their 10-year commitment in 2017 to explore the use of AI across a... Read More

Booth (#2500) will showcase AI-enabled innovations and digital solutions that enhance clinical decision making and provide personalized patient care ORLANDO, Fla. / Mar 07, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) will showcase its industry-leading portfolio of artificial intelligence (AI)-enabled medical devices and digital solutions in Booth 2500 at the Health Information and Management Systems Society (HIMSS)... Read More

LOGIQ E10 Series and LOGIQ Fortis include new features and AI-based tools to advance imaging capabilities for high-quality assessments; new “LOGIQ AppAPI” enables third-party applications to extend capabilities, including PIUR IMAGING “PIUR tUS inside” 3D imaging solution for thyroid examination Introducing LOGIQ Totus, a multi-purpose, versatile ultrasound solution designed for full-body imaging in a variety of clinical... Read More

Collaboration supports the patient journey across the care continuum and eases transitions and care from the hospital to home CHICAGO and BOSTON , Feb. 26, 2024 /PRNewswire/ -- GE HealthCare (Nasdaq: GEHC) and Biofourmis have announced a strategic collaboration aimed at enhancing continuity of care by enabling safe, effective, and accessible care in the home to support the patient journey beyond the hospital setting. The... Read More

10-year collaboration aims to expand the reach of innovative technology and digital solutions to more than one million patients. CHICAGO / Feb 19, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a collaboration with OSF HealthCare, an integrated health system caring for patients throughout Illinois and Michigan, and Pointcore, Inc., a healthcare management and non-clinical shared services company, to help... Read More

CHICAGO / Feb 16, 2024 / Business Wire / G E HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 13,000,000 shares of its common stock (the “GEHC Shares”) at a public offering price of $82.25 per share ($80.605 per share, net of underwriting discount). GE HealthCare is not selling any... Read More

CHICAGO / Feb 15, 2024 / Business Wire / GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 13,000,000 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the... Read More

CHICAGO / Feb 14, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), is announcing today that its Vice President and Chief Financial Officer, Jay Saccaro, will be presenting at the following upcoming investor conferences. Citi Unplugged MedTech and Life Sciences Access Day – February 29, 2024 at 10:15 am ET in New York City Oppenheimer Annual Healthcare MedTech and Services Conference (Virtual) – March 12, 2024 at 12:00 pm... Read More

CHICAGO / Feb 08, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MedQuest Associates (MedQuest), a leading owner, operator, and manager of outpatient diagnostic imaging facilities, today announced a three-year collaboration to deliver excellence in patient care by providing access to innovative technologies from GE... Read More

Delivers Strong Financial and Operating Performance in First Year as Public Company Fourth Quarter 2023 Revenue growth was 5% year-over-year; Organic revenue growth* of 5% Net income margin was 7.7% versus 11.2% for the prior year; Adjusted Earnings Before Interest and Taxes (EBIT) margin* was 16.1% versus the fourth quarter of 2022 Standalone Adjusted EBIT margin* of 16.1% Cash flow from operating activities was $1.1... Read More

Delivers Strong Financial and Operating Performance in First Year as Public Company Fourth Quarter 2023 Revenue growth was 5% year-over-year; Organic revenue growth* of 5% Net income margin was 7.7% versus 11.2% for the prior year; Adjusted Earnings Before Interest and Taxes (EBIT) margin* was 16.1% versus the fourth quarter of 2022 Standalone Adjusted EBIT margin* of 16.1% Cash flow from operating activities was $1.1... Read More

GE HealthCare receives FDA clearance for expanded indication for Novii+ maternal and fetal monitoring solution for pregnant patients ≥34 weeks. Novii+ noninvasively measures and displays fetal heart rate, maternal heart rate and uterine activity, while providing patient comfort and mobility in the hospital. CHICAGO / Feb 01, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance... Read More

Latest digital platform provides key advancements to help maintain high signal fidelity while reducing environmental noise Forward-looking platform designed to help enable path to new technologies in the electrophysiology (EP) lab CHICAGO / Jan 31, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system , to help clinicians... Read More

CHICAGO / Jan 18, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its fourth quarter and full year 2023 financial results before the market opens on Tuesday, February 6, 2024. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time on that same day, which will be a live webcast and accessible at... Read More

The anticipated acquisition aligns to GE HealthCare’s precision care strategy with the goal of strengthening the company’s digital solutions across care pathways MIM Software provides AI-enabled image analysis and workflow tools across multiple care areas, including oncology, urology, neurology, and cardiology Today’s agreement reinforces GE HealthCare’s commitment to integrate medical imaging products in order to deliver... Read More

CHICAGO / Dec 18, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC) is announcing today that President and Chief Executive Officer, Peter Arduini, and Vice President and Chief Financial Officer, Jay Saccaro, will attend the 42 nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9 th in San Francisco. Both GE HealthCare executives will participate in a Q&A session following Arduini’s presentation at 2:15 pm... Read More

CHICAGO / Dec 08, 2023 / Business Wire / The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per share of Common Stock for the fourth quarter of 2023 payable on February 15, 2024 to all shareholders of record as of January 16, 2024. About GE HealthCare GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator,... Read More

AirStrip visualization is currently deployed across more than 600 healthcare systems in the U.S. Joint commercialization agreement provides expansion of AirStrip Cardiology and Patient Monitoring solutions exclusively through GE HealthCare Collaboration provides healthcare systems with a deeply integrated offering and comprehensive ecosystem of solutions to enhance patient care and outcomes AirStrip and GE HealthCare... Read More

GE HealthCare is proud to announce the addition of True Enhance DL to its Effortless Recon DL portfolio CHICAGO / Nov 29, 2023 / Business Wire / Through its leading imaging solutions and commitment to innovation, GE HealthCare (NASDAQ: GEHC) remains at the forefront of leveraging deep learning, a subset of artificial intelligence (AI), to benefit a multitude of clinicians and patients. True Enhance DL i for CT is the latest... Read More

As part of the latest Critical Care Suite 2.1 offering, new on-device AI helps detect and localize pneumothorax (PTX) – providing immediate notification and overlay for the presence or absence of PTX. Results from various clinical studies showed significant user benefits - including a 57% reduction in reporting times for... Read More

New offering provides an all-in-one AI platform optimized for mammography, that seamlessly integrates artificial intelligence (AI) applications from iCAD to aid clinicians in breast cancer detection as well as breast density assessment and notification. CHICAGO / Nov 27, 2023 / Business Wire / Today GE HealthCare (Nasdaq: GEHC) announced the release of a new, all-in-one platform of artificial intelligence (AI) apps to... Read More

Booth (#7326) will highlight new product introductions, key innovations, and AI-enabled advancements from the company’s comprehensive portfolio of Imaging, Ultrasound, and digital solutions designed to optimize patient care and increase operational efficiencies CHICAGO / Nov 26, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC) will highlight more than 40 innovations, including several key artificial intelligence... Read More

IONIC Health will add multi-vendor, multi-modality remote scanning capabilities to GE HealthCare's portfolio of effortless operations solutions, including the recently FDA-cleared Digital Expert Access with remote scanning. CHICAGO / Nov 21, 2023 / Business Wire / GE HealthCare ( Nasdaq: GEHC) has received U.S. FDA 510(k) Clearance for the new version of Digital Expert Access with remote scanning, the first remote patient... Read More

The 10-year strategic collaboration builds on strong research foundations in medical imaging and expands the scope to advance the delivery of personalized and quality healthcare into 2030 and beyond. Both organizations are members of Wisconsin’s public-private consortium, led by BioForward, that helped secure the state’s prestigious Phase 1 Regional Technology and Innovation Hub designation. MADISON, Wis. / Nov 17, 2023 /... Read More

CHICAGO / Nov 14, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC), is announcing today that President and Chief Executive Officer, Peter Arduini, and Vice President and Chief Financial Officer, Jay Saccaro, will hold a fireside chat from the RSNA 2023 annual meeting on Wednesday, November 29 th at 9:15 am ET/8:15 am CT. The discussion will be hosted by Joanne Wuensch, Managing Director, Equity Research – Medical... Read More

Long-term relationship will focus on the potential for new advancements to expand patient and clinician access and transform the approach to discovery, diagnosis, and treatment of cancer and other disease states. CHICAGO / Nov 13, 2023 / Business Wire / As demand for Theranostic care increases, GE HealthCare (NASDAQ: GEHC ) and BAMF Health are excited to announce a collaboration aimed at enabling BAMF Health to scale turnkey... Read More

New data supports the potential role of Artificial Intelligence (AI) in predicting patients’ response to immunotherapies in advance of their treatment. AI models demonstrated 70 to 80 percent accuracy in predicting both the likelihood of efficacious response and specific immune-related toxicities. Enables clinicians to match... Read More

Revenue growth was 5% year-over-year; Organic revenue growth* of 6% Net income attributable to GE HealthCare was $375 million versus $487 million for the prior year; Adjusted EBIT* $744 million versus $700 million Net income margin was 7.8% versus 10.6% for the prior year; Adjusted EBIT margin* was 15.4% versus Standalone EBIT margin* of 14.2% Diluted EPS was $0.83 versus $1.07 for the prior year; Adjusted EPS* was $0.99... Read More

The average 250-bed hospital in the U.S. has approximately 2,000 medical devices that may require end-of-life monitoring and planning for potential disposition. 1 GE HealthCare and reLink Medical will help healthcare providers manage their end-of-life medical equipment, and provide them with a potential revenue stream, by... Read More

FDA’s list of AI-enabled device authorizations includes almost 700 devices; 58 are from GE HealthCare – more than any other medical technology company. CHICAGO / Oct 24, 2023 / Business Wire / GE HealthCare has topped a U.S. Food and Drug Administration (FDA) list of artificial intelligence (AI) enabled medical devices with 58 listed 510(k) clearances or authorizations to date in the United States. GE HealthCare also topped... Read More

New technologies in interventional cardiology further enhance the company’s comprehensive portfolio of cardiology solutions across the full continuum of care – including the next generation of image-guided systems Allia IGS Pulse for cardiac imaging; new capabilities for seamless, multi-modality integration with INTERACT... Read More

Personalized peripheral focused ultrasound therapy has potential as non-invasive, non-pharmacological alternative for chronic disease management Encouraging pre-clinical and early clinical data indicate potential use for people with type 2 diabetes Collaboration pairs GE HealthCare expertise in ultrasound technology with Novo Nordisk long-term experience in metabolic disease treatment and management to develop solution to... Read More

CHICAGO / Oct 17, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its third quarter 2023 financial results before the market opens on Tuesday, October 31, 2023. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time on that same day, which will be a live webcast and accessible at... Read More

Building on the award-winning Allia platform for image guided therapies, the new Allia IGS Pulse was designed to improve workflow for the diagnosis and treatment of cardiovascular diseases in interventional cardiology. As part of its new image chain, the system features the first monopolar x-ray tube used for interventional... Read More

Study finds that continuous monitoring of vital signs (respiratory rate, oxygen saturation and pulse rate) with Portrait Mobile results in alarm data which may be used to optimize system configuration and mitigate alarm fatigue in the ward environment. Study results revealed at the American Society of Anesthesiologists (ASA) Annual Meeting. SAN FRANCISCO / Oct 15, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC) today... Read More

Advanced ultrasound technology with artificial intelligence applications to support clinicians of all skill levels in efficiently diagnosing lung pathology and traumatic injury, which increases efficiency in routine delivery of care and could prove especially valuable during mass casualty situations when facilities experience an influx of patients requiring swift evaluation and treatment CHICAGO / Oct 12, 2023 / Business... Read More

A global licensing agreement has been signed for the development and commercialization of SOFIE’s two investigational Gallium-68 and Fluorine-18 Fibroblast Activation Protein Inhibitors (FAPI) radiopharmaceutical diagnostics - [ 68 Ga]FAPI-46 and outside-U.S. rights for [ 18 F]FAPI-74 FAP is highly expressed in cancer... Read More

Unique from current CT technology, GE HealthCare’s proprietary photon counting CT design is engineered to leverage Deep Silicon detectors with the goal of capturing more patient data for clearer images and detailed information to help inform diagnoses across care areas Researchers at Stanford Medicine will collaborate with GE HealthCare for the intended future benefit of clinicians and patients – scanning human subjects on a... Read More

AI-powered technology will expand access to scans by enabling a broader set of healthcare providers to perform cardiac exams with real-time guidance at the point of care Venue Family Ultrasound Systems are the first GE HealthCare products to integrate Caption Guidance software Caption Guidance software is part of Verisound suite of technologies designed to help clinicians work smarter and more efficiently CHICAGO / Oct 06,... Read More

Technology-powered collaboration aims to deliver AI-enabled devices and digital solutions at the enterprise level to increase clinical and operational efficiencies, drive workflow enhancements and improve patient outcomes CHICAGO / Oct 05, 2023 / Business Wire / Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE HealthCare and University Hospitals (UH) today announced a... Read More

CHICAGO / Sep 22, 2023 / Business Wire / The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC), a leading medical technology, pharmaceutical diagnostics, and digital solutions innovator, today declared a cash dividend of $0.03 per share of Common Stock for the third quarter of 2023 payable on November 15, 2023 to all shareholders of record as of October 20, 2023. About GE HealthCare GE HealthCare is a... Read More

First Sustainability Report since becoming an independent company in January 2023 underscores the Company’s commitment to corporate responsibility and embodies its purpose to create a world where healthcare has no limits Highlights include the reduction of operational Scope 1 and 2 greenhouse gas (GHG) emissions by 27% since 2019 Continued progress will be driven by a strong leadership focus on ESG and sustainability efforts... Read More

Grant from Bill & Melinda Gates Foundation will facilitate development of AI-assisted applications and tools to enable healthcare professionals with less experience to perform quick and accurate ultrasound scans to help address maternal and fetal health and respiratory diseases AI-assisted ultrasound algorithms will be developed to run on multiple ultrasound devices to expand access to high quality care around the world with... Read More

Combining the world-class clinical and research expertise of Mayo Clinic with the deep research, engineering, and product development expertise of GE HealthCare, this new collaboration aims to forge an integrated innovation engine to advance the practice of radiology and care to patients worldwide. ROCHESTER, Minn. / Sep 14, 2023 / Business Wire / Today, Mayo Clinic and GE HealthCare announce a strategic healthcare... Read More

In preliminary tests, the AI-enabled algorithm was able to correctly predict the missed care opportunity (MCO) at rates of up to 96% 1 . CHICAGO / Sep 06, 2023 / Business Wire / GE HealthCare and Mass General Brigham announced, as part of its initial collaboration, the co-development of an artificial intelligence (AI) algorithm that will help increase operations effectiveness and productivity. The first innovative AI... Read More

With a dual-headed probe, the Vscan Air SL offers a sector array and a linear array on a single device which is ideal for switching between focused cardiac assessments and vascular assessments right at the point of care – both inside and outside of the hospital. Vscan Air SL is the newest addition to the Vscan product suite,... Read More

Integrating and analyzing data over time and across various data sources, CardioVisio for Atrial Fibrillation helps visualize the history of the patient’s heart and provides guideline-directed insights to healthcare providers. CHICAGO / Aug 24, 2023 / Business Wire / Today, GE HealthCare (Nasdaq: GEHC) announces the launch of CardioVisio for Atrial Fibrillation (AFib), a digital tool designed to assist clinicians in... Read More

Hamilton, ON, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Mohawk College and McMaster University announced today the opening of the Centre for Integrated and Advanced Medical Imaging (CIAMI), a new facility for educational training, imaging research, and increased magnetic resonance imaging (MRI) access for patient care. CIAMI provides a space where education, clinical care, and research intersect through collaborative and unique... Read More

CHICAGO / Aug 24, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC), is announcing today that members of its senior management team will be presenting at the following investor conferences next month. Wells Fargo 2023 Healthcare Conference – September 7, 2023 at 8:00 am ET in Boston Morgan Stanley 21 st Annual Global Healthcare Conference – September 12, 2023 at 1:35 pm ET in New York City These events can be accessed by... Read More

Genpact's deep domain, digital and process expertise to enhance financing capabilities for GE Healthcare's customers acquiring new medical equipment and services through loans, leases, and other financial structures. NEW YORK , Aug. 22, 2023 /PRNewswire/ -- Genpact (NYSE: G), a global professional services firm focused on delivering outcomes that transform businesses, announced a new multi-year agreement with GE HealthCare... Read More

GE HealthCare’s smart phone-sized Portrait Mobile frees the patient from the hospital bed while providing continuous monitoring of vital signs, using wearable sensors with a wireless protocol, to help catch inpatient deterioration early. Portrait Mobile introduces an innovative measurement technology to continuously capture... Read More

2Q Revenue growth of 7% year-over-year; Organic revenue growth* of 9% 2Q Net income attributable to GE HealthCare of $418 million versus $485 million for the prior year, Adjusted EBIT* of $711 million versus $719 million 2Q Diluted EPS was $0.91 versus $1.04 in the prior year, Adjusted EPS* was $0.92 versus $1.15 Raises full-year guidance for Organic revenue growth* and Adjusted EPS* on strong execution in first half of year... Read More

CHICAGO / Jun 29, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its second quarter 2023 financial results before the market opens on Tuesday, July 25, 2023. The GE HealthCare management team will also host a conference call and webcast at 8:00 a.m. Eastern Time on that same day, which will be a live webcast and accessible at... Read More

The company will showcase its latest innovative solutions to enable rapid diagnosis, Theranostics, and precision care at #SNMMI23 Clinicians and patients are aligned in what they want: A healthcare experience that is more human and flexible, focusing on the needs of both clinicians and patients i Precision medicine is a growing field that aims to improve health outcomes by precisely diagnosing and treating medical... Read More

CHICAGO / Jun 23, 2023 / Business Wire / The Board of Directors of GE HealthCare Technologies Inc . (Nasdaq: GEHC), a leading medical technology, pharmaceutical diagnostics, and digital solutions innovator, today declared a cash dividend of $0.03 per share of Common Stock for the second quarter of 2023 payable on August 15, 2023 to all shareholders of record as of July 21, 2023. About GE HealthCare GE HealthCare is a leading... Read More

CHICAGO / Jun 23, 2023 / Business Wire / GE HealthCare i s set to unveil SIGNA PET/MR AIR i , at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2023 annual meeting. The company will showcase the integration of its advanced AIR technologies with the SIGNA PET/MR AIR system, to enhance diagnostic precision,... Read More

CHICAGO / Jun 21, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC) has entered into a distribution agreement with DePuy Synthes*, the Orthopaedics Company of Johnson & Johnson, to bring GE HealthCare’s OEC 3D Imaging System, in conjunction with DePuy Synthes’ extensive product portfolio, to more surgeons and patients across the United States. This new collaboration demonstrates GE HealthCare’s ongoing commitment to bring... Read More

The first patient has been scanned in a Phase I clinical trial for an investigational fluorine-18 ( 18 F) CD8-targeted imaging radiopharmaceutical 18 F-CD8 Positron Emission Tomography (PET) radiopharmaceutical could allow both same-day and subsequent sequential imaging, potentially facilitating earlier monitoring of a... Read More

CHICAGO / Jun 07, 2023 / Business Wire / GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 25,000,000 shares of its common stock (the “GEHC Shares”) at a public offering price of $78.00 per share. GE HealthCare is not selling any shares of common stock and will not receive any... Read More

Patients and clinicians are united in a vision for the future; low trust in AI, interoperability, burnout, and care accessibility top the list of challenges. Double-blinded quantitative survey of 5,500 patients and patient advocates along with 2,000 clinicians across eight countries, as well as qualitative interviews, examined clinician and patient sentiment about today’s healthcare system. CHICAGO / Jun 06, 2023 / Business... Read More

CHICAGO / Jun 05, 2023 / Business Wire / GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 25,000,000 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the... Read More

Sonic DL i is a deep learning (DL) technology that acquires high-quality magnetic resonance (MR) images up to 12 times ii faster than conventional methods, enabling cardiac imaging within a single heartbeat When applied to cardiac MRI, Sonic DL extends access to cardiac patients with arrhythmias and breath-holding challenges, helping to ensure swift, consistent, and more comfortable exams With up to an 83% reduction in scan... Read More

NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that GE HealthCare Technologies Inc. (Nasdaq: GEHC), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX), the Nasdaq-100 Equal Weighted Index (Nasdaq: NDXE), and the Nasdaq-100 Ex-Tech Sector Index (Nasdaq: NDXX) prior to market open on Wednesday, June 7, 2023. GE HealthCare Technologies Inc. will replace Fiserv, Inc. (Nasdaq: FISV)... Read More

A type of artificial intelligence (AI), Deep Learning (DL) technology can advance medical imaging capabilities by providing more robust, accurate, and data-driven information as well as support more efficient workflows and exams Precision DL for PET/CT is the latest addition to GE HealthCare’s Effortless Recon DL portfolio of deep learning-based solutions – which also includes AIR Recon DL for MRI, TrueFidelity for CT, and... Read More

St Luke’s $30 million investment in 21 GE HealthCare CT systems makes it one of the health system’s largest investments of its kind Continuous Artificial Intelligence (AI) and software updates will be provided by GE HealthCare’s Smart Subscription, a service to help extend the life of the CT Fleet CHICAGO / May 25, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leading medical technology innovator, announced today... Read More

NCCN Guidelines ® for clinicians and patients now recommend the use of FES PET for ER+ positive disease under certain circumstances during the systemic staging workup of patients with recurrent or metastatic breast cancer (MBC). Cerianna (fluoroestradiol F18) injection is the first and only U.S. Food and Drug Administration... Read More

NEW YORK / May 24, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, is announcing today that its President and CEO Peter Arduini will present at the Jefferies Healthcare Conference in New York City on June 7, 2023 from 10:30 am to 10:55 am ET. This event can be accessed live by visiting GE HealthCare’s Investor Relations website at: https://wsw.com/webcast/jeff281/gehc/1817530.... Read More

Showcasing Intelligent RT, Auto Segmentation and an updated MR Radiation Therapy Suite, designed to optimize the radiation oncology care pathway and help reduce the critical time between patient intake and first treatment dose VIENNA / May 12, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC) is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto Segmentation, and an updated Magnetic... Read More

CHICAGO / May 09, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, has named James "Jay” Saccaro as vice president and chief financial officer (CFO), succeeding Helmut Zodl who is remaining with the Company to lead special projects regarding separation from GE. These changes will take effect June 1, 2023. Saccaro joins GE HealthCare from Baxter International, a global medtech... Read More

The expansion of the bkActiv system into Urology, Colorectal and Pelvic Floor surgeries provides surgeons in these fields the ability to visualize anatomical structures and have greater control over the course of the procedure CHICAGO / Apr 26, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC) announced today the next-generation bkActiv is now available for guiding urology, colorectal and pelvic floor surgical procedures.... Read More

1Q Revenue growth of 8% year-over-year; Organic revenue* growth of 12% 1Q Net income attributable to GE HealthCare of $372 million versus $389 million for the prior year, Adjusted EBIT* of $664 million versus $599 million 1Q Diluted EPS was $0.41 versus $0.86 in the prior year, Adjusted EPS* was $0.85 versus $0.96 Board of Directors declared a cash dividend of $0.03 per share for the first quarter of 2023 CHICAGO / Apr 25,... Read More

CARESCAPE Canvas builds on GE HealthCare’s 50+ years of clinical excellence and provides a unified patient monitoring solution that is reliable, flexible, scalable and intuitive to use CHICAGO / Apr 20, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced US FDA 510(k) clearance of its CARESCAPE Canvas patient... Read More

CHICAGO / Apr 18, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC) is further advancing its precision care strategy with CT-Navigation, which offers clinicians detailed, real-time, 3D computed tomography (CT) images for stereotactic needle guidance across an array of care areas, including interventional and oncological procedures as well as biopsies, ablations, drainage, therapeutics and more. Interventional radiology –... Read More

CHICAGO / Apr 17, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leader in health technology, will showcase its growing portfolio of digital platforms and solutions at the Health Information and Management Systems Society, Inc. (HIMSS) Global Health Conference and Exhibition in Chicago from April 17-21, 2023. “We are transforming healthcare by delivering advanced technology to improve patients care options,... Read More

CHICAGO / Apr 05, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its first quarter 2023 financial results before the market opens on Tuesday, April 25, 2023. The GE HealthCare management team will also host a conference call and webcast at 8:00 a.m. Eastern Time on that same day, which will be a live webcast and accessible at... Read More